Law Firm Probes Option Care Health Merger Deal for Shareholders
Monteverde & Associates is investigating Option Care Health over a potential merger, raising shareholder rights concerns.
A New York-based class action law firm has opened an investigation into Option Care Health, Inc. (NASDAQ: OPCH), examining whether the home infusion therapy company's shareholders are being adequately protected in connection with a potential merger or acquisition transaction.
Monteverde & Associates PC, led by class action attorney Juan Monteverde, announced the probe. The firm has been recognized as a Top 50 firm in the 2025 ISS Securities Class Action Services Report and has recovered millions of dollars on behalf of investors in prior cases.
Read more Retail Investing Platforms Top 41 Million Accounts in Record Run →
Shareholder investigations of this nature typically focus on whether a company's board of directors fulfilled its fiduciary duties during deal negotiations — including whether the sale price reflects fair value and whether proper procedures were followed in evaluating competing offers. No litigation has been announced at this stage.
Option Care Health is a publicly traded provider of home and alternate-site infusion services. Shareholders who hold OPCH stock and have concerns about a potential transaction are being encouraged by the firm to come forward for a consultation before any legal deadlines pass.
Continue reading at All Financial Services & Investing.
